International Clinical Trials Day 2019
20 May 2019
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
We want to take today to say a special thank you to our wonderful Clinical Trials team, and extend our appreciation to the many thousands of dedicated people that undertake clinical trials to advance medicine and treatments for patients. Today is also an opportunity to recognise patients and their contribution to finding a cure by choosing to participate in our trials.
Our 20-person team based at the Poche Centre is currently coordinating 18 actively recruiting trials, while maintaining follow-up for a further 23. The trials coordinated by the team range from surgical and dermatological trials, through the spectrum of available medical and radiation oncology trials, including immunotherapy, targeted therapy, and radiation therapy. In 2018, 244 new patients were enrolled in clinical trials at MIA, while 665 were in the follow-up stages.
“We are very fortunate here at MIA to have an extremely hardworking and inspiring Clinical Trials team who are one hundred percent dedicated to our patients,” says Co-Medical Director Professor Richard Scolyer.
Co-Medical Director Professor Georgina Long adds, “Clinical trials lead to advances in treatment that create better outcomes for our patients – continually pushing the boundaries and conducting these trials is what is going to help us achieve our goal of zero deaths of melanoma.”
International Clinical Trials Day commemorates the day Scottish doctor James Lind began the first ever clinical trial in 1747, using different groups of sailors to identify the link between fruit and the prevention of scurvy. Lind changed modern medicine with his study, so every year International Clinical Trials Day is celebrated to appreciate and highlight the work of those in Clinical Trials.
Clinical Trials Manager Maria Gonzalez echoed the sentiments of the whole team, “We all come to work each day for the same reason: to help patients and find a cure.”
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.
Melanoma patients now have greater access to subsidised immunotherapy thanks to additional treatments today being listed on the PBS.
Brisbane couple Leon and Tamra Betts were, like thousands of others around Australia, on the couch watching MAFS when newlywed Natasha ran through her weekly beauty routine. When they heard the 26-year-old mention solarium use, they were shocked, and then saddened, prompting this open letter to all young Australians.
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.